IDEAYA Biosciences, Inc. (IDYA) [Rocket]

Overview

IDEAYA Biosciences, Inc. (IDYA)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/23/2023	4	Stone Paul A. (CFO) has filed a Form 4 on IDEAYA Biosciences, Inc.
08/18/2023	4	Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2023	4	Throne Jason (Chief Legal Officer) has filed a Form 4 on IDEAYA Biosciences, Inc.
08/11/2023	4	Stone Paul A. (CFO) has filed a Form 4 on IDEAYA Biosciences, Inc.
08/10/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/10/2023	8-K	Quarterly results
08/09/2023	144	Form 144 - Report of proposed sale of securities:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
Revenues	50.9	89.5	27.9	58.2	19.5	0.0	0.0	0.0
Revenue growth	82.3%	54.0%	43.0%
Cost of goods sold	0.0	113.4	0.0	78.2	0.0	0.0	0.0	0.0
Gross profit	50.9	-23.9	27.9	-20.1	19.5	0.0	0.0	0.0
Gross margin	100.0%	-26.7%	100.0%	-34.5%	100.0%
Selling, general and administrative	113.4		78.2		54.9
Research and development						34.3	31.7	12.4
General and administrative		23.9		20.1		10.0	4.7	2.1
EBIT	-54.8	-62.5	-49.3	-50.3	-33.6	-44.3	-36.4	-14.4
EBIT margin	-107.6%	-69.8%	-176.3%	-86.4%	-172.1%
Pre-tax income	-58.7	-58.7	-49.8	-49.8	-34.5	-42.0	-34.3	-11.9
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-58.7	-58.7	-49.8	-49.8	-34.5	-42.0	-34.3	-11.9
Net margin	-115.2%	-65.5%	-178.1%	-85.6%	-176.6%

Diluted EPS	($1.42)	($1.42)	($1.41)	($1.41)	($1.40)	($3.36)	($35.92)	($17.06)
Shares outstanding (diluted)	41.4	41.4	35.3	35.3	24.7	12.5	1.0	0.7

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.